As the average human life expectancy has increased, so too has the impact of ageing and age-related disease on our society. Ageing research is now the focus of thousands of laboratories that include leaders in the areas of genetics, molecular and cellular biology, biochemistry, and behaviour. Ageing Research Reviews (ARR) covers the trends in this field. It is designed to fill a large void, namely, a source for critical reviews and viewpoints on emerging findings on mechanisms of ageing and age-related disease. Rapid advances in understanding of mechanisms that control cellular proliferation, differentiation and survival are leading to new insight into the regulation of ageing. From telomerase to stem cells to energy and oxyradical metabolism, this is an exciting new era in the multidisciplinary field of ageing research. The cellular and molecular underpinnings of manipulations that extend lifespan, such as caloric restriction, are being identified and novel approaches for preventing age-related diseases are being developed. ARR publishes articles on focussed topics selected from the broad field of ageing research, with an emphasis on cellular and molecular mechanisms of the aging process and age-related diseases such as cancer, cardiovascular disease, diabetes and neurodegenerative disorders. Applications of basic ageing research to lifespan extension and disease prevention are also covered in this journal.
Aging Brain is an Open Access journal that complements Neurobiology of Aging which, in its 40th anniversary in 2020, is the premier journal in the field of aging neuroscience. Aging Brain will publish papers that contribute to knowledge of the mechanisms underlying healthy (or adaptive) and pathological aging of the brain, as well as the iterative communication of signals between the brain, other organs and the external environment that promote or disrupt the mental health span. Papers that employ multiple levels of analysis, that integrate knowledge from established and emerging disciplines and technological developments, and which demonstrate translation into improved medical approaches, are particularly welcome.The journal accepts: Original research, Reviews, Short Communications, Registered Reports, Point of Interest and Letters to the Editor, provided they demonstrate originality, scientific rigor, observance of ethical standards and represent a significant contribution to the field.At the same time, and notwithstanding the above-mentioned criteria, it will serve as a platform for the presentation early reports and ideas that will stimulate research on brain aging. Registered Reports will be of interest to clinical scientists, but also to researchers undertaking experiments in animals.
Official Journal of The International Society of Vascular Behavioural and Cognitive DisordersCerebral Circulation - Cognition & Behavior (CCCB) is a peer-reviewed open access journal that publishes articles relevant to the progress and understanding of vascular dementia and Alzheimer disease. An online-only journal, CCCB considers original papers and review articles in clinical, experimental and basic science research. CCCB welcomes submissions in the fields of vascular cognitive disorders, vascular cognitive impairment, vascular dementia, vascular depression, cerebral blood flow, aging and cognition, cerebrovascular factors to degenerative dementia.In particular, CCCB is interested in:Population-based studies on vascular dementiaPublic Health aspects for planning and implementation of prevention programs in vascular dementia at population levelCorrelation studies dealing with cognitive effects of large-vessel strokesStudies on the effects of hypoperfusion due to heart disease or circulatory disturbancesAdvances in brain imaging in the pathogenesis of vascular dementiaAdvances in fluid biomarkers for diagnostic purposes and in the pathogenesis of vascular cognitive disordersBasic and clinical research on the role of sleep and glymphatic circulation in vascular and degenerative forms of dementia.Clinical studies on the multiple manifestations of vascular cognitive disordersStudies on executive function in vascular dementiaDevelopment of bedside tests and correlations with imaging methodsAnimal models of amyloid angiopathy and other models relevant to vascular dementiaControlled clinical trials of more effective treatments for vascular dementia and its neuropsychiatric complicationsStudies on traditional and newer risk factors and mechanisms of control, including hypertension, metabolism, lipids, endocrinology, dietetics, nutrition, diabetes, cardiology and cardiovascular surgeryBenefits to authors We provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Read more about our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, you can visit our Support Center.
The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology.Editor-in-Chief, Supriya Mohile, University of Rochester, USA and the Editorial Board invite you to submit a manuscript to the Journal of Geriatric Oncology. The journal welcomes the submission of manuscripts in the following categories:• Original research articles • Review articles • Clinical trials • Education and training articles • Short communications • Perspectives • Meeting reports • Letters to the EditorThe Journal of Geriatric Oncology is the official journal of the International Society of Geriatric Oncology (SIOG).Journal of Geriatric Oncology's Inclusion and Diversity Pledge This journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader?ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.
Neurobiology of Aging publishes the results of studies in behavior, biochemistry, cell biology, endocrinology, molecular biology, morphology, neurology, neuropathology, pharmacology, physiology and protein chemistry in which the primary emphasis involves mechanisms of nervous system changes with age or diseases associated with age. Reviews and primary research articles are included, occasionally accompanied by open peer commentary. Letters to the Editor and brief communications are also acceptable. Brief reports of highly time-sensitive material are usually treated as rapid communications in which case editorial review is completed within six weeks and publication scheduled for the next available issue. The accepted abbreviation for Neurobiology of Aging for bibliographic citation is Neurobiol. AgingBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: https://service.elsevier.comAuthors are also welcome to submit their manuscripts to the journal's open access companion title, Aging Brain.